​

Grace Therapeutics (GRCE) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Grace Therapeutics Revenue Highlights

00

Grace Therapeutics Revenue by Period

Grace Therapeutics Revenue by Year

DateRevenueChange
2025-03-31-100.00%
2024-03-31-100.00%
2023-03-31-100.00%
2022-03-31--100.00%
2021-03-31$196.00K100.00%
2020-03-31-100.00%
2019-03-31-100.00%
2018-03-31-100.00%
2017-03-31--100.00%
2016-02-29$27.79K-87.15%
2015-02-28$216.29K-51.95%
2014-02-28$450.16K-36.36%
2013-02-28$707.39K6653.17%
2012-02-29$10.47K-63.93%
2011-02-28$29.04K100.00%
2010-02-28--

Grace Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Grace Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30--100.00%
2025-03-31$8.00K100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30--100.00%
2021-03-31$115.00K41.98%
2020-12-31$81.00K100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30--100.00%
2016-11-30$936.33100.00%
2016-08-31--100.00%
2016-05-31$2.21K-85.14%
2016-02-29$14.90K292.75%
2015-11-30$3.79K-28.20%
2015-08-31$5.29K27.45%
2015-05-31$4.15K-96.94%
2015-02-28$135.60K439.00%
2014-11-30$25.16K262.84%
2014-08-31$6.93K-86.58%
2014-05-31$51.68K-69.01%
2014-02-28$166.75K524.55%
2013-11-30$26.70K-89.42%
2013-08-31$252.47K3973.46%
2013-05-31$6.20K-77.53%
2013-02-28$27.58K-93.54%
2012-11-30$427.16K78.75%
2012-08-31$238.97K1703.03%
2012-05-31$13.25K-10.50%
2012-02-29$14.81K100.00%
2011-11-30-100.00%
2011-08-31--100.00%
2011-05-31$84.94K192.51%
2011-02-28$29.04K100.00%
2010-11-30-100.00%
2010-08-31-100.00%
2010-05-31-100.00%
2010-02-28-100.00%
2009-11-30--

Grace Therapeutics generated - in revenue during Q2 2026, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Grace Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
LVTXLAVA Therapeutics$11.98M-
XLOXilio Therapeutics$6.34M$19.07M
ABVCABVC BioPharma$508.83K-
RNXTRenovoRx$43.00K$266.00K
OKUROnKure Therapeutics--
LTRNLantern Pharma--
PDSBPDS Bio--
CALCCalciMedica--
TVRDTvardi Therapeutics--
GRCEGrace Therapeutics--

GRCE Revenue FAQ

What is Grace Therapeutics’s yearly revenue?

Grace Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. GRCE's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Grace Therapeutics’s quarterly revenue?

Grace Therapeutics's quarterly revenue for Q2 2026 was $0, a 100.00% increase from the previous quarter (Q1 2026), and a 0% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $0, a -100.00% decrease from the previous quarter (Q4 2025), and a 0% increase year-over-year (Q1 2025). GRCE's quarterly revenue for Q4 2025 was $8K, a 100.00% increase from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024).

What is Grace Therapeutics’s revenue growth rate?

Grace Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was -100.00%.